Clinical Trials
75 trialsTolerability and Bioavailability of Utidelone Capsule in Patients With Advanced Solid Tumors
Beijing Biostar Pharmaceuticals Co., Ltd.
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors
Shanghai Juncell Therapeutics
A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours
Shanghai Best-Link Bioscience, LLC
Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients
Bio-Thera Solutions
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
1200 Pharma, LLC
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SKI-G-801 in Patients With Advanced Solid Tumors
Oscotec Inc.
Clinical Study of IAH0968 in Patients With HER2-positive Advanced Solid Tumors
SUNHO（China）BioPharmaceutical CO., Ltd.
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
Shouyao Holdings (Beijing) Co. LTD
Phase I Study of BL0020, a Novel Anti-tumor Drug, in Adult Subjects With Advanced Solid Tumors
Shanghai Best-Link Bioscience, LLC
Clinical Pharmacokinetic Study of Lurbinectedin in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Impairment
PharmaMar
Tolerability of Utidelone Capsule in Patients With Advanced Solid Tumors
Beijing Biostar Pharmaceuticals Co., Ltd.
A Study of EMB-09 in Participants With Advanced or Metastatic Solid Tumors.
Shanghai EpimAb Biotherapeutics Co., Ltd.
Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors
Beijing Likang Life Science and Tech Co., Ltd.
A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
A Study of 7MW3711 in Subjects With Advanced Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation
Shouyao Holdings (Beijing) Co. LTD
A Study of QLF3108 in Participants With Advanced Solid Tumor
Qilu Pharmaceutical Co., Ltd.
IMMINENT-01
Immix Biopharma, Inc.
Phase I Study of QLS1103 in Subjects With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
A Clinical Study of TQB3823 in Patients With Advanced Malignant Tumor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS Mutation
Shanghai YingLi Pharmaceutical Co. Ltd.
A Study of PM1015 in Patients With Advanced Solid Tumors
Biotheus Inc.
Phase I/II Study of αPD1-MSLN-CAR T Cells in MSLN-positive Advanced Solid Tumors
Shanghai Cell Therapy Group Co.,Ltd
A Study of SHR-1802 in Combination With Adebrelimab in Patients With Advanced Solid Tumors
Shanghai Hengrui Pharmaceutical Co., Ltd.
A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor
Shouyao Holdings (Beijing) Co. LTD
A Study of IMC008 for Advanced Solid Tumors
Changhai Hospital
A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
IMM2902 in Patients With Advanced Solid Tumors Expressing HER2
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
A Phase I Study of QL1604 for Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
A Study of TFX05-01 in Patients With Advanced Solid Tumors
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.
A Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors
I-Mab Biopharma US Limited
ARTEMIS-001: Phase 1 Study of the HS-20093 in Patients With Advanced Solid Tumors
Hansoh BioMedical R&D Company
A Study of HB0030 Injection in Patients With Advanced Solid Tumors
Huabo Biopharm Co., Ltd.
Study to Access Anti-CD38 Anibody Drug in Patients With Advanced Solid Tumors
Sorrento Therapeutics, Inc.
TT-00973-MS Tablets in Patients With Advanced Solid Tumors
TransThera Sciences (Nanjing), Inc.
A Clinical Trial of ICP-192 in Treated Patients With Advanced Solid Tumors With FGF/FGFR Gene Alterations
Beijing InnoCare Pharma Tech Co., Ltd.
Study on the Treatment of Advanced Malignant Solid Tumor With Revottack and PD-1 Inhibitor
The Affiliated Hospital of Xuzhou Medical University
Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
A Study of CS1001 in Combination With Donafenib in Subjects With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
A Study of Intratumoral Administration of Oncolytic Virus Injection (RT-01) in Patients With Advanced Solid Tumors
The First Affiliated Hospital of Bengbu Medical University
Safety, Tolerability and Pharmacokinetics Study of QLS31904 in Patients With Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
FLIGHT
Etern BioPharma (Shanghai) Co., Ltd
FIRST
Etern BioPharma (Shanghai) Co., Ltd
B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors
The First People's Hospital of Lianyungang
A Phaseâ… Study of HS-10381 in Patients With Advanced Solid Tumors
Jiangsu Hansoh Pharmaceutical Co., Ltd.
A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor
Shanghai YingLi Pharmaceutical Co. Ltd.
A Phase I Trial of Simmitinib in Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
A Study of Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors
The Affiliated Hospital of Xuzhou Medical University
SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors
Etern BioPharma (Shanghai) Co., Ltd
A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.